Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$4.15 - $8.37 $97,815 - $197,280
-23,570 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$4.45 - $10.63 $2,287 - $5,463
-514 Reduced 2.13%
23,570 $137,000
Q2 2021

Aug 12, 2021

SELL
$8.11 - $11.11 $993,629 - $1.36 Million
-122,519 Reduced 83.57%
24,084 $249,000
Q4 2020

Feb 25, 2021

BUY
$14.15 - $17.19 $2.07 Million - $2.52 Million
146,603 New
146,603 $2.27 Million

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $67M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.